Author: Gareth

Research Peptides in the UK — The Honest Legal and Safety Guide Research Peptides in the UK There are two kinds of sites in this space when it comes to legal and safety information. Those that bury it in small print at the bottom of a page nobody reads. And those that put it front…

Tesofensine — The Accidental Weight Loss Compound That Outperformed Expectations Tesofensine Some of the most interesting discoveries in medicine happen by accident. Tesofensine was never designed to be a weight loss compound. It was developed by Danish pharmaceutical company NeuroSearch as a treatment for Parkinson’s disease and Alzheimer’s — a neurological drug targeting the brain’s…

5-Amino-1MQ — The NNMT Inhibitor That Targets the Enzyme Keeping Your Fat Cells in Storage Mode 5-Amino-1MQ There is an enzyme operating in your fat cells right now that most people have never heard of. It is called NNMT — nicotinamide N-methyltransferase — and in people with metabolic dysfunction, excess body fat or age-related metabolic…

AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue AOD-9604 Sometimes the most interesting compounds are not the ones that make the biggest headlines. While semaglutide and tirzepatide have dominated the weight loss conversation with their dramatic clinical trial numbers, AOD-9604 has quietly built a committed and loyal following in the research…

Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss 28.7% average body weight reduction. In a Phase 3 clinical trial. Over 68 weeks. To put that number in context — most bariatric surgery procedures produce average weight loss of between 25% and 30%. The most effective pharmaceutical compound previously available —…